The role of paraproteins in kidney damage in patients with lymphoproliferative diseases

Por O. N. Pysarevskaya, A. N. Kotelnikova, S. P. Kazakov, N. P. Potekhin, O. A. Rukavitsyn
Publicado em 2019-10-01

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study

Por S. V. Semochkin, E. G. Arshanskaya, O. D. Zakharov, A. N. Kotelnikova, S. S. Kulikova, E. V. Ovanesova, Yu. B. Kochkareva, V. L. Ivanova
Publicado em 2015-06-01

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study

Por S. V. Semochkin, E. G. Arshanskaya, O. D. Zakharov, A. N. Kotelnikova, S. S. Kulikova, E. V. Ovanesova, Yu. B. Kochkareva, V. L. Ivanova
Publicado em 2015-06-01